Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Brief Psychological Intervention to Reduce Alcohol Consumption

30 de junio de 2026 actualizado por: Emma Brown, Lancaster University
Continuous levels of hazardous alcohol consumption (i.e., 14 or more units per week) is one of the leading risk factors of ill health and early mortality, contributing to around 9,809 deaths a year in the UK. The aim of the present research is to test the effect of helping people to reward themselves when they have successfully reduced/abstained from their previous levels of alcohol consumption. Each participant will be randomly allocated to one of two conditions. The trial requires 128 participants to perform a fully powered statistical analysis. The two conditions include: (1) a control condition (asked to form a plan to reduce/abstain from alcohol consumption), or (2) a weekly self-incentivising condition (asked to reward themselves at the end of each week that they have successfully reduced/abstained their previous levels of alcohol consumption). The main outcome measure will be units of alcohol consumed/not consumed, which will be self-reported at 1-week and 1-month follow-up time points.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Descripción detallada

The research aims to test the role of self-incentivising implementation intentions for reductions/abstinence of alcohol consumption among people aged 18 and over, residing in the UK, and consuming 14 units of more of alcohol at the start of the study. The effectiveness of self-incentives has been successfully seen previously within health behaviour change, has not been tested in reduction/abstinence of alcohol consumption. Therefore, this research will build on what is known about the effectiveness of self-incentives used for increasing fruit and vegetable consumption, and smoking cessation.

This study is a randomised controlled trial with the between participants factor of condition which has two levels:

1. Control (plan) or 2. Weekly self-incentivising implementation intention.

The within participants' factor will be time which has three levels:

Baseline (T1) Follow-up (T2) (1-week following baseline) Follow-up (T3) (1-month following baseline)

An ethical concern is that participants in the control condition may struggle more to reduce/abstain from alcohol consumption as they will not have the additional benefits of being within an experimental condition which uses self-incentives to aid their attempt. A control condition is needed to monitor if changes to alcohol consumption is due to the use of self-incentives or another behaviour change technique.

The recruitment process will recruit participants to complete an online questionnaire (via Qualtrics), from Prolific. Prolific is an online recruitment platform, which allows screeners to be set (e.g., age, residency, consumption level) prior to contacting potential participants. Prolific then contacts the participants to which the screeners apply, and the participants can decide if they would like to take part. The researcher can then set restrictions to only allow completion of the follow-up questionnaires, based on those participants who completed the online questionnaire at baseline.

All participants who are able to provide informed consent, are over the age of 18 years old, resident in the UK (due to discrepancies in the safe recommended alcohol consumption rates across countries), are eligible to take part in the study. Unfortunately, the study does not cater for people who cannot understand English at the present time, although this will be monitored for amendments in future studies.

The participant information sheet included prior to the online questionnaire includes details about the study, costs and benefits of taking part in the study, and the right to consent and withdraw at any point throughout the study. There are no risks involved in taking part in the study. Participants are reimbursed via Prolific based on the expected time to complete each questionnaire (i.e., £3.55 per questionnaire completed, which equates to more than the current UK living wage). There is a minimal burden in time taken to complete the questionnaires, which should take no longer than 15 minutes per time point, though this time estimation is considered generous.

In terms of confidentiality, participants will not provide any identifier other than their Prolific ID. This ensures that no identifying information is available to the research team, but that the participant can be added to the screener for completion of the baseline questionnaires, and that all questionnaires (baseline, 1-week follow-up, and 1-month follow-up) can be matched.

There are no conflicts of interest. Participants are provided with contact details of the research team, should they like to contact for a summary of the results.

Tipo de estudio

Intervencionista

Inscripción (Actual)

228

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Lancaster, Reino Unido
        • Lancaster University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • Aged 18 years or over
  • Able to understand written English
  • Competent to provide informed consent
  • Residing in the UK
  • Regularly consuming 14 units of alcohol or more at baseline

Exclusion Criteria:

  • Note aged 18 years old or over
  • Not able to understand written English
  • Not competent to provide informed consent
  • Not residing in the UK
  • Not regularly consuming 14 units of alcohol or more at baseline

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Behavioural: Self-incentive
Weekly self-incentivising
Participants read a brief statement designed to encourage them to reduce/abstain from alcohol consumption (we would like you to plan to reduce/abstain your alcohol consumption). Participants are then asked to specify a self-incentive on which they could implement at the end of each week which they have been successful.
Comparador activo: Plan
Control
Participants read a brief statement designed to encourage them to reduce/abstain from alcohol consumption (we would like you to plan to reduce/abstain your alcohol consumption). Participants are then asked to form their plan.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Alcohol consumption
Periodo de tiempo: Up to 1-month
Total units of alcohol consumed in last week
Up to 1-month

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Alcohol use disorders identification test (AUDIT)
Periodo de tiempo: Up to 1- month
Changes in AUDIT scores
Up to 1- month
Compliance to self-incentivise
Periodo de tiempo: Up to 1-month
Whether participants allocated to the intervention self-incentives
Up to 1-month
Frequency of self-incentivisation
Periodo de tiempo: Up to 1-month
How frequently participants allocated to the intervention condition use self-incentives
Up to 1-month
Self-incentives used
Periodo de tiempo: Up to 1-month
What self-incentives are chosen by participants (monetary, BCT etc)
Up to 1-month

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

20 de mayo de 2026

Finalización primaria (Actual)

21 de junio de 2026

Finalización del estudio (Actual)

21 de junio de 2026

Fechas de registro del estudio

Enviado por primera vez

30 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

30 de junio de 2026

Publicado por primera vez (Actual)

7 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

7 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

30 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • FHM-2024-4354-RECR-4

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Descripción del plan IPD

Data may be shared if this complies with ethical guidelines

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .